Two Sigma Investments, LP Bio N Tech Se Transaction History

Two Sigma Investments, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$80.36 - $102.87 $936,435 - $1.2 Million	11,653 New	11,653 $936,000
Q4 2023 Feb 14, 2024	SELL	$90.91 - $112.75 $554,551 - $687,775	-6,100 Reduced 73.49%	2,200 $232,000
Q2 2023 Aug 14, 2023	BUY	$102.58 - $129.66 $851,414 - $1.08 Million	8,300 New	8,300 $895,000
Q4 2022 Feb 14, 2023	BUY	$118.43 - $186.05 $1.1 Million - $1.73 Million	9,300 New	9,300 $1.4 Million
Q3 2021 Nov 15, 2021	SELL	$205.93 - $447.23 $45.4 Million - $98.6 Million	-220,492 Reduced 79.22%	57,831 $15.8 Million
Q2 2021 Aug 16, 2021	BUY	$113.32 - $241.49 $31.5 Million - $67.2 Million	278,323 New	278,323 $62.3 Million
Q1 2021 May 17, 2021	SELL	$85.73 - $119.5 $10.4 Million - $14.5 Million	-121,635 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$72.71 - $129.54 $8.84 Million - $15.8 Million	121,635 New	121,635 $9.92 Million

356

38.4M

2.12M

2.17M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $25.1B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.